Article info
Basic and translational research
Extended report
Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice
- Correspondence to Dr Mariana J Kaplan, Systemic Autoimmunity Branch, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, 10 Center Dr, 10/6D47C, Bethesda, MD 20892-1560, USA; mariana.kaplan{at}nih.gov
Citation
Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice
Publication history
- Received February 7, 2014
- Revised July 15, 2014
- Accepted July 17, 2014
- First published August 7, 2014.
Online issue publication
November 10, 2015
Article Versions
- Previous version (7 August 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/